Arno Therapeutics, Inc. (OTCMKTS:ARNI – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares changing hands.
Arno Therapeutics Stock Performance
Arno Therapeutics Company Profile
Arno Therapeutics, Inc, a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men.
See Also
- Five stocks we like better than Arno Therapeutics
- What is Forex and How Does it Work?
- 3 Legacy Tech Companies Reemerging as AI Leaders
- Compound Interest and Why It Matters When Investing
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Using the MarketBeat Stock Split Calculator
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Arno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arno Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
